Literature DB >> 22366579

Tumor necrosis factor-associated susceptibility to type 1 diabetes is caused by linkage disequilibrium with HLA-DR3 haplotypes.

Neeraj Kumar1, Gurvinder Kaur, Nikhil Tandon, Narinder Mehra.   

Abstract

Tumor necrosis factor-α (TNF-α) is an important proinflammatory cytokine involved in the pathogenesis of autoimmune type 1 diabetes (T1D). The TNF gene locus is located in the major histocompatibility complex (MHC) class III region and its genetic polymorphisms have been reported to be associated with T1D. However, it is not clear whether these associations are primary or caused by their linkage disequilibrium with other predisposing genes within the MHC. We have tested 2 TNF-α single nucleotide polymorphisms at positions -308G/A and -238G/A in the 5' untranslated region and a (GT)n microsatellite TNFa in the North Indian healthy population and T1D patients with known HLA-A-B-DR-DQ haplotypes. The allele frequencies of TNFa5, -308A, and -238G were determined to be significantly increased among patients compared with controls. Although the observed positive association of -238G was caused by its presence on all 3 DR3(+) groups, namely, B8-DR3-DQ2, B50-DR3-DQ2, and B58-DR3-DQ2 haplotypes associated with T1D in this population, the increase of the -308A allele was caused by its association with the latter 2 haplotypes. On the other hand, TNF -308G occurred on B8-DR3 haplotypes along with -238G and TNFa5 alleles, particularly in T1D patients with late disease onset (at >20 years of age). These results indicate that TNF associations with T1D are caused by their linkage disequilibrium with specific HLA-DR3-DQ2 haplotypes in the Indian population. Because polymorphisms in the promoter region regulate TNF expression levels (e.g., -308A), they retain crucial immunological significance in the development of T1D and its management.
Copyright © 2012 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22366579     DOI: 10.1016/j.humimm.2012.01.012

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  6 in total

1.  Associations between TNF gene polymorphisms (-308 A/G, -238 A/G, -1031 C/T and -857 T/C) and genetic susceptibility to T1D: a meta-analysis.

Authors:  Peng-Fei Wen; Xiao-Song Wang; Min Zhang; Han Cen; Hai-Feng Pan; Qian-Ling Ye; Chen Mao; Dong-Qing Ye
Journal:  Endocrine       Date:  2014-02-11       Impact factor: 3.633

2.  Association of Tumor Necrosis Factor-Alpha-308 G/A and -238 G/A Polymorphism with Diabetic Retinopathy: A Systematic Review and Updated Meta-Analysis.

Authors:  Wenna Gao; Ruilin Zhu; Liu Yang
Journal:  Ophthalmic Res       Date:  2020-12-04       Impact factor: 2.892

3.  Understanding type 1 diabetes through genetics: Advances and prospects.

Authors:  Nikhil Tandon
Journal:  Indian J Endocrinol Metab       Date:  2015-04

4.  Segregation Analysis of Genotyped and Family-Phased, Long Range MHC Classical Class I and Class II Haplotypes in 5 Families With Type 1 Diabetes Proband in the United Arab Emirates.

Authors:  Guan K Tay; Halima Al Naqbi; Aurélie Mawart; Zahrah Baalfaqih; Anoud Almaazmi; Asma Deeb; Habiba Alsafar
Journal:  Front Genet       Date:  2021-06-30       Impact factor: 4.599

5.  High producer haplotype (CAG) of -863C/A, -308G/A and -238G/A polymorphisms in the promoter region of TNF-α gene associate with enhanced apoptosis of lymphocytes in HIV-1 subtype C infected individuals from North India.

Authors:  Sukhvinder Singh; Aman Sharma; Sunil K Arora
Journal:  PLoS One       Date:  2014-05-16       Impact factor: 3.240

6.  Environmental exposure to BDE47 is associated with increased diabetes prevalence: Evidence from community-based case-control studies and an animal experiment.

Authors:  Zhan Zhang; Shushu Li; Lu Liu; Li Wang; Xue Xiao; Zhenzhen Sun; Xichen Wang; Chao Wang; Meilin Wang; Lei Li; Qiujin Xu; Weimin Gao; Shou-Lin Wang
Journal:  Sci Rep       Date:  2016-06-13       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.